Total Payments
$276.20
2024 Payments
$112.59
Companies
9
Transactions
15
Medicare Patients
2,430
Medicare Billing
$566,935
Payment Breakdown by Category
Food & Beverage$161.36 (58.4%)
Education$114.84 (41.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $161.36 | 11 | 58.4% |
| Education | $114.84 | 4 | 41.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $61.20 | 1 | $0 (2019) |
| AKEBIA THERAPEUTICS INC | $54.60 | 3 | $0 (2024) |
| Travere Therapeutics, Inc. | $49.21 | 4 | $0 (2024) |
| Vifor Pharma, Inc. | $27.52 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $23.39 | 1 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $19.44 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $15.20 | 1 | $0 (2019) |
| Mallinckrodt LLC | $14.31 | 1 | $0 (2018) |
| Amgen Inc. | $11.33 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $112.59 | 7 | Travere Therapeutics, Inc. ($49.21) |
| 2022 | $24.67 | 2 | AKEBIA THERAPEUTICS INC ($12.53) |
| 2021 | $19.44 | 1 | Fresenius USA Marketing, Inc. ($19.44) |
| 2020 | $17.46 | 1 | AKEBIA THERAPEUTICS INC ($17.46) |
| 2019 | $76.40 | 2 | Otsuka America Pharmaceutical, Inc. ($61.20) |
| 2018 | $14.31 | 1 | Mallinckrodt LLC ($14.31) |
| 2017 | $11.33 | 1 | Amgen Inc. ($11.33) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Hyperkalemia | ||||||
| 10/21/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $23.39 | General |
| 08/07/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.89 | General |
| 08/07/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $11.55 | General |
| 08/07/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $2.88 | General |
| 02/01/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 09/27/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Nephrology | ||||||
| 06/09/2022 | Vifor Pharma, Inc. | — | Education | In-kind items and services | $12.14 | General |
| 05/07/2021 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/07/2020 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: NEPHROLOGY | ||||||
| 09/25/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Education | In-kind items and services | $61.20 | General |
| Category: NEPHROLOGY | ||||||
| 02/14/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/21/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 03/06/2017 | Amgen Inc. | Sensipar (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 517 | 1,339 | $309,172 | $122,870 |
| 2022 | 12 | 624 | 1,602 | $350,931 | $131,906 |
| 2021 | 10 | 657 | 1,891 | $399,409 | $157,858 |
| 2020 | 9 | 632 | 1,689 | $384,564 | $154,301 |
Total Patients
2,430
Total Services
6,521
Medicare Billing
$566,935
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 197 | 715 | $99,671 | $43,587 | 43.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 19 | 92 | $64,919 | $25,139 | 38.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 18 | 102 | $59,662 | $23,223 | 38.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 82 | 94 | $24,850 | $9,182 | 36.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 107 | $26,900 | $7,460 | 27.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 55 | $11,018 | $5,144 | 46.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 55 | 111 | $8,409 | $4,333 | 51.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 29 | 41 | $5,865 | $2,086 | 35.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $4,264 | $1,500 | 35.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,614 | $1,217 | 33.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 222 | 842 | $117,465 | $45,685 | 38.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 22 | 82 | $57,893 | $21,925 | 37.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 19 | 85 | $49,723 | $19,243 | 38.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 110 | 117 | $30,949 | $11,995 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 100 | $25,183 | $6,399 | 25.4% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 19 | 36 | $14,427 | $5,721 | 39.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 37 | 76 | $15,248 | $5,698 | 37.4% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 16 | 69 | $11,686 | $4,618 | 39.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 34 | 77 | $11,019 | $4,189 | 38.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $6,982 | $2,751 | 39.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 50 | 89 | $6,740 | $2,605 | 38.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,616 | $1,077 | 29.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 267 | 1,064 | $150,025 | $59,598 | 39.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 26 | 139 | $94,011 | $38,365 | 40.8% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 21 | 66 | $37,915 | $15,312 | 40.4% |
About Dr. Brian Zimmer, D.O
Dr. Brian Zimmer, D.O is a Nephrology healthcare provider based in Blawnox, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962430348.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Zimmer, D.O has received a total of $276.20 in payments from pharmaceutical and medical device companies, with $112.59 received in 2024. These payments were reported across 15 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($161.36).
As a Medicare-enrolled provider, Zimmer has provided services to 2,430 Medicare beneficiaries, totaling 6,521 services with total Medicare billing of $566,935. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Blawnox, PA
- Active Since 06/28/2006
- Last Updated 07/11/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1962430348
Products in Payments
- SAMSCA (Drug) $61.20
- Vafseo (Drug) $24.61
- Velphoro (Drug) $19.44
- AURYXIA (Drug) $17.46
- Veltassa (Drug) $15.38
- LOKELMA (Drug) $15.20
- ACTHAR (Biological) $14.31
- Auryxia (Drug) $12.53
- Sensipar (Drug) $11.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.